Cargando…

CT-based radiomics model with machine learning for predicting primary treatment failure in diffuse large B-cell Lymphoma

Biomarkers which can identify Diffuse Large B-Cell Lymphoma (DLBCL) likely to be refractory to first-line therapy are essential for selecting this population prior to therapy initiation to offer alternate therapeutic options that can improve prognosis. We tested the ability of a CT-based radiomics a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago, Raoul, Ortiz Jimenez, Johanna, Forghani, Reza, Muthukrishnan, Nikesh, Del Corpo, Olivier, Karthigesu, Shairabi, Haider, Muhammad Yahya, Reinhold, Caroline, Assouline, Sarit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348197/ https://www.ncbi.nlm.nih.gov/pubmed/34343854 http://dx.doi.org/10.1016/j.tranon.2021.101188

Ejemplares similares

Radiomics and Artificial Intelligence for Biomarker and Prediction Model Development in Oncology
por: Forghani, Reza, et al.
Publicado: (2019)

Radiomics and machine learning for the diagnosis of pediatric cervical non-tuberculous mycobacterial lymphadenitis
por: Al Bulushi, Yarab, et al.
Publicado: (2022)

Dual-Energy CT Texture Analysis With Machine Learning for the Evaluation and Characterization of Cervical Lymphadenopathy
por: Seidler, Matthew, et al.
Publicado: (2019)

Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models
por: Liu, Xiaoyang, et al.
Publicado: (2021)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype Differentiation
por: Enke, Johanna S., et al.
Publicado: (2022)

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Sehn, Laurie H., et al.
Publicado: (2020)

An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma
por: Burke, John M., et al.
Publicado: (2018)

Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma
por: Benoit, Alexandre, et al.
Publicado: (2022)

Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma
por: Frood, Russell, et al.
Publicado: (2022)

Above and Beyond Age: Prediction of Major Postoperative Adverse Events in Head and Neck Surgery
por: Mascarella, Marco A., et al.
Publicado: (2021)

Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics
por: Han, Eun Ji, et al.
Publicado: (2022)

Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma
por: Haider, Stefan P., et al.
Publicado: (2020)

CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations
por: Jensen, Laura J., et al.
Publicado: (2022)

Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomics
por: Haider, Stefan P., et al.
Publicado: (2020)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Assessing radiomics feature stability with simulated CT acquisitions
por: Flouris, Kyriakos, et al.
Publicado: (2022)

Prediction of Overall Survival and Progression-Free Survival by the (18)F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma
por: Zhou, Yi, et al.
Publicado: (2019)

Development and validation of a [(18)F]FDG PET/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients
por: Li, Mingshan, et al.
Publicado: (2022)

Comparison of radiomics models and dual-energy material decomposition to decipher abdominal lymphoma in contrast-enhanced CT
por: Bernatz, Simon, et al.
Publicado: (2023)

Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas
por: Sabaté-Llobera, Aida, et al.
Publicado: (2016)

[18F]FDG-PET/CT Demonstration of Young Adult Onset Stills Disease Mimicking Lymphoma
por: Nawwar, Ayah Adel, et al.
Publicado: (2022)

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
por: Eertink, J. J., et al.
Publicado: (2023)

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Bartlett, Nancy L., et al.
Publicado: (2023)

Diffuse Infiltrative Splenic Lymphoma: Diagnostic Efficacy of Arterial-Phase CT
por: Lee, Jeong Eun, et al.
Publicado: (2016)

Multiparametric detection and outcome prediction of pancreatic cancer involving dual-energy CT, diffusion-weighted MRI, and radiomics
por: Koch, Vitali, et al.
Publicado: (2023)

Ability of (18)F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
por: Ou, Xuejin, et al.
Publicado: (2019)

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma
por: Andorsky, David J., et al.
Publicado: (2018)

Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
por: Oikonomou, Anastasia, et al.
Publicado: (2018)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
por: Assouline, Sarit, et al.
Publicado: (2012)

Radiomics Driven Diffusion Weighted Imaging Sensing Strategies for Zone-Level Prostate Cancer Sensing
por: Dulhanty, Chris, et al.
Publicado: (2020)

Dataset on acute stroke risk stratification from CT angiographic radiomics
por: Avery, Emily W., et al.
Publicado: (2022)

Methodological framework for radiomics applications in Hodgkin’s lymphoma
por: Sollini, Martina, et al.
Publicado: (2020)

Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway
por: Pera, Benet, et al.
Publicado: (2018)

Prognostic Value of Baseline Radiomic Features of (18)F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
por: Lue, Kun-Han, et al.
Publicado: (2020)

Baseline (18)F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2023)

Rare Intracardiac Tumor: Primary Cardiac Lymphoma Presenting as Atypical Angina
por: Aimanan, Karthigesu, et al.
Publicado: (2016)

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

Correlations between Functional Imaging Markers Derived from PET/CT and Diffusion-Weighted MRI in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
por: Wu, Xingchen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_813fb59f7kgnnkma5v2f7htjq8